Superhuman stock

Private-market facts for current and former Superhuman employees researching their stock.

Latest Round
Series C
Valuation
$13B
Founded
2014
Headquarters
San Francisco, CA
Founders
Rahul Vohra
Status
private

Talk to a Superhuman stock specialist

Get personalized guidance on your Superhuman shares — including current market activity, pricing context, and liquidity options.

Speak with an expert

Overview

Premium email client designed for speed and productivity, featuring keyboard shortcuts, AI-powered triage, scheduled sends, and read receipts.

Selling Superhuman shares

Why shareholders consider selling

Shareholders in Superhuman may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Superhuman does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.

Can you sell Superhuman stock?

Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Enterprise Software sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Superhuman shares would be outlined in the holder's equity agreement or the company's governing documents.

What affects the value of Superhuman shares?

The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Enterprise Software market conditions, and any recent private-market transaction activity. Data points such as the company's Series C round and its reported $13B valuation can help frame expectations, though they do not guarantee a transaction price.

What should holders check before selling

  • The type of security held (common shares, preferred, options, RSUs)
  • Whether the equity is fully vested and, for options, whether it has been exercised
  • Any transfer restrictions, lock-up provisions, or company approval requirements
  • Estimated net proceeds after applicable taxes and transaction fees
  • Whether partial liquidity — selling a portion rather than the full position — may be a better fit

Tools for Superhuman shareholders

Exploring equity in Superhuman often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.

Latest funding round

Superhuman most recently raised a Series C round . The company was valued at $13B. Total funding raised to date is approximately $108M.

Lead investors in this round include Andreessen Horowitz and First Round Capital.

Founders & company background

Superhuman was founded in 2014 by Rahul Vohra and is headquartered in San Francisco, CA.

Investors

Industry

Similar private companies

Latest Superhuman news

Talk to a Superhuman stock specialist

Get personalized guidance on your Superhuman shares — including current market activity, pricing context, and liquidity options.

Speak with an expert

Frequently asked questions

Is Superhuman still a private company?
Yes, Superhuman is currently a private company.
What is Superhuman's latest funding round?
Superhuman's most recent known round is Series C.
What is Superhuman's valuation?
Superhuman's latest reported valuation is $13B.
Who are the investors in Superhuman?
Notable investors include Andreessen Horowitz, First Round Capital, Y Combinator.
Can I sell my Superhuman stock?
Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands Superhuman stock can help you evaluate your options.

Related pages

Last verified: 2026-04-13 · Superhuman data compiled from funding disclosures, investor announcements, corporate filings, and public records.

Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.